Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Sinovac Biotech Ltd.    SVA   AGP8696W1045

SINOVAC BIOTECH LTD.

(SVA)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancials 
Business Summary
Logo Sinovac Biotech Ltd.
Sinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza and mumps. The Company's pipeline consists of vaccine candidates in the clinical and pre-clinical development Phases in China. The Company is engaged in the sales, marketing, manufacturing and development of vaccines for infectious disease. The Company develops various products, including Healive, Bilive, Anflu, Panflu Whole Viron Pandemic Influenza Vaccine, Split Viron Pandemic Influenza Vaccine, Panflu.1, RabEnd, Mumps Vaccine, Enterovirus 71 (EV71) Vaccine, Pneumococcal Polysaccharide Vaccine, Pneumococcal Conjugate Vaccine, Rubella Vaccine, Varicella Vaccine and Sabin Inactivated Polio Vaccine.

Number of employees : 910 people.
Sales per Business
20182019Delta
USD (in Million)%USD (in Million)%
Enterovirus 71 Vaccines162.5470.8%149.2260.6% -8.19%
Inactivated Hepatitis Vaccines63.4327.6%57.9523.6% -8.63%
Mumps Vaccines1.660.7%19.738% +1089.39%
Influenza Vaccines2.030.9%19.157.8% +844.03%
Sales per region
20182019Delta
USD (in Million)%USD (in Million)%
China215.1293.7%227.1192.3% +5.57%
Foreign Countries14.536.3%18.947.7% +30.36%
Managers and Directors
NameAgeSinceTitle
Wei Dong Yin, Dr.572003Chairman, President, CEO, Secretary & MD
Nan Wang542013Chief Financial Officer & Vice President
Qiang Gao442016Vice President-Research & Development
Yuk Lam Lo722006Independent Director
Jian Li522011Independent Director
Meng Mei532012Independent Director
Simon J. Anderson592004Independent Director
Shan Fu522018Independent Director
Helen G. Yang--Investor Relations Contact
Xiao Mei Yin562017Vice President-Sales & Marketing
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 98,903,243 45,138,108 45.6% 0 0.0% 45.6%
Shareholders
NameEquities%
1Globe Capital LLC 18,515,315 26.0%
SAIF Advisors Ltd. 10,780,820 15.2%
Wei Dong Yin 6,359,500 8.94%
CDH Investment Advisory Pte. Ltd. 6,000,000 8.43%
Vivo Capital LLC 5,900,000 8.29%
Sansar Capital Management LLC 2,953,503 4.15%
Martin Currie Investment Management Ltd. 2,025,666 2.85%
Manning & Napier Advisors LLC 1,435,270 2.02%
Davis Selected Advisers LP 1,250,546 1.76%
The Leuthold Group LLC (Investment Management) 1,223,360 1.72%
Company contact information
Sinovac Biotech Ltd.
No. 15 Zhi Tong Road
Zhongguancun Science & Technology
Changping District
Beijing 102200

Phone : +86.10.5693.1800
Web : http://www.sinovacbio.com